BGC » Chemicals A-Z » IRAK-1-4 Inhibitor I

Identify Suppliers 2025 Properties Safty ☰

Identify Suppliers 2025 Properties Safty

IRAK-1-4 Inhibitor I

BGC Id:	265555513588
CAS No:	509093-47-4
Synonyms:	benzamide, n-[1-[2-(4-morpholinyl)ethyl]-1h-benzimidazol-2-yl]-3-nitro- ; 3-nitro-n-(1-(2-morpholin-4-ylethyl)-1h-benzimidazol-2-yl)benzamide ; 1-(2-(4-morpholinyl)ethyl)-2-(3-nitrobenzoylamino)benzimidazole ; n-(2-morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole ; interleukin-1 receptor-associated-kinase-1/4 inhibitor ; iirak-1-4 inhibitor i ; n-(2-morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole, 1-(2-(4-morpholinyl)ethyl)-2-(3-nitrobenzoylamino)benzimidazole ; irak-1/4 inhibitor i ; irak-1/4 inhibitor
Molecular Formula:	C20H21N5O4
Molecular Weight:	395.417
EINECS:

Verified providers in 2025

The following 2 notable providers have been checked and can be recommended.

BOC Sciences

Description : IRAK-1-4 Inhibitor I is a novel benzimidazole that is a potent inhibitor of interleukin-1 receptor-associated kinases 1-4 (IRAK 1-4).

Molecular Weight :395.41
Purity :> 98%

Molecular Formula : C20H21N5O4 Canonical SMILES : C1COCCN1CCN2C3=CC=CC=C3N=C2NC(=O)C4=CC(=CC=C4)[N+](=O)[O-] InChI : InChI=1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22 >>more

Leap Chem

Molecular Formula: C20H21N5O4 Molecular Weight: 395.417 Hazard Symbols: T UN Number: UN 2811 6.1/PG 3 WGKGermany: 3

What other providers are available for CAS 509093-47-4?

The last intensive check and update was carried out on 2025/03/11.

Identify

Synonyms:

benzamide, n-[1-[2-(4-morpholinyl)ethyl]-1h-benzimidazol-2-yl]-3-nitro- ; 3-nitro-n-(1-(2-morpholin-4-ylethyl)-1h-benzimidazol-2-yl)benzamide ; 1-(2-(4-morpholinyl)ethyl)-2-(3-nitrobenzoylamino)benzimidazole ; n-(2-morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole ; interleukin-1 receptor-associated-kinase-1/4 inhibitor ; iirak-1-4 inhibitor i ; n-(2-morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole, 1-(2-(4-morpholinyl)ethyl)-2-(3-nitrobenzoylamino)benzimidazole ; irak-1/4 inhibitor i ; irak-1/4 inhibitor

CAS:

509093-47-4

EINECS:

Molecular Formula:

C20H21N5O4

MDL:

Properties

Molecular Weight:

395.417 g·mol−1

Density:

1.40

Suppliers

BOC Sciences

Тип компании: Supplier

BOC Sciences provides a wide range of customer services, bulk and specialty compounds to the pharmaceutical, agrochemical and biotechnology industries. We intend to offer you the products and services of the highest quality at the most reasonable, cost efficient prices. Most of our compounds can be supplied ranging from mg to kg and arrive with analytic report. Мы поставщик Trityl olmesartan medoxomil. We hope to add immense value to your research projects!

страна: USA телефон: +1-631-485-4226 факс: +1-631-614-7828

INQUIRY | ORDER

» contact details

Leap Chem Co., Ltd

Тип компании: Bulk and laboratory supplier

страна: P.R.China
телефон: +852-30606658

LEAPChem, a specialized fine chemicals supplier for research, development and production. LEAPChem provides nearly 50,000 rare and innovative chemical products to support the evolving needs of our customers in research & bulk manufacturing activities. As a highly customer-oriented enterprise, we are committed to providing high-quality customer services and products to our global customers in a cost-effective and efficient manner. Our client list includes many major pharmac ...

INQUIRY | ORDER

» contact details

Safety Information

Hazard Symbols: T

Europe standard Hazard pictograms, code and definition

Hazard Classes:

Risk Codes:

25-36/37/38 (R)

Safety Codes:

26-36/37-45 (S)

RID / ADR:

UN 2811 6.1 / PG 3

Storage temperature:

2-8°C

What other providers are available for CAS 509093-47-4?

In addition to the providers presented here for IRAK-1-4 Inhibitor I with the CAS number 509093-47-4, there are other 3 providers with slightly different product names available for this CAS number.

Irak-1/4 inhibitor

BIOZOL Diagnostica Vertrieb GmbH +1 additional providers that we know from the past

Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor

+1 additional providers that we know from the past